NATCOPHARM.NSNATCOPHARM.NSNSE
Loading
Cash Flow Under PressureContracting
Percentile Rank87
3Y CAGR+11.9%
5Y CAGR+31.8%
Year-over-Year Change
Cash generated from core business operations
3Y CAGR
+11.9%/yr
vs +6.1%/yr prior
5Y CAGR
+31.8%/yr
Recent deceleration
Acceleration
+5.8pp
Accelerating
Percentile
P87
Within normal range
vs 5Y Ago
4x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $11.91B | -29.8% |
| 2025 | $16.97B | +40.0% |
| 2024 | $12.12B | +42.7% |
| 2023 | $8.49B | +1726.0% |
| 2022 | $465.00M | -84.4% |
| 2021 | $2.99B | -28.4% |
| 2020 | $4.17B | -37.6% |
| 2019 | $6.69B | +44.3% |
| 2018 | $4.64B | +34.1% |
| 2017 | $3.46B | - |